Search filters

List of works by Hengjiang Dong

A Noncanonical Role for Plasminogen Activator Inhibitor Type 1 in Obesity-Induced Diabetes

scientific article published on 02 May 2019

A role of apolipoprotein D in triglyceride metabolism

scientific article

APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.

scientific article published on 23 January 2017

ATF4 protein deficiency protects against high fructose-induced hypertriglyceridemia in mice.

scientific article published on 25 July 2013

Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism

scientific article published on 21 September 2006

Altered FoxO1 and PPARγ interaction in age-related ER stress-induced hepatic steatosis

scientific article published on 01 June 2019

Angiopoietin-1 production in islets improves islet engraftment and protects islets from cytokine-induced apoptosis

scientific article published on 27 June 2007

Central effects of humanin on hepatic triglyceride secretion

scientific article published on 9 June 2015

Challenges for gene therapy of type 1 diabetes.

scientific article

Deficiency in AIM2 induces inflammation and adipogenesis in white adipose tissue leading to obesity and insulin resistance

scientific article published on 11 September 2019

Depletion of hepatic forkhead box O1 does not affect cholelithiasis in male and female mice

scientific article published on 09 April 2020

Effect of Hypertriglyceridemia on Beta Cell Mass and Function in ApoC3 Transgenic Mice.

scientific article published on 11 May 2016

Effect of hepatic insulin expression on lipid metabolism in diabetic mice.

scientific article

Effects of apoA-V on HDL and VLDL metabolism in APOC3 transgenic mice

scientific article

Elevated vascular endothelial growth factor production in islets improves islet graft vascularization.

scientific article published in April 2004

Evolution of hepatic steatosis to fibrosis and adenoma formation in liver-specific growth hormone receptor knockout mice

scientific article

FOXO1 Mediates the Autocrine Effect of Endothelin-1 on Endothelial Cell Survival

scientific article published on May 8, 2012

Forkhead Box O6 (FoxO6) Depletion Attenuates Hepatic Gluconeogenesis and Protects against Fat-induced Glucose Disorder in Mice.

scientific article published on 5 May 2015

Forkhead Box Protein 1 (FoxO1) Inhibits Accelerated β Cell Aging in Pancreas-specific SMAD7 Mutant Mice.

scientific article

FoxO integration of insulin signaling with glucose and lipid metabolism.

scientific article published on 17 February 2017

FoxO1 Plays an Important Role in Regulating β-Cell Compensation for Insulin Resistance in Male Mice.

scientific article published on 4 January 2016

FoxO1 and hepatic lipid metabolism

scientific article published on June 1, 2009

FoxO1 links hepatic insulin action to endoplasmic reticulum stress

scientific article

FoxO1 links insulin resistance to proinflammatory cytokine IL-1beta production in macrophages.

scientific article published on 03 August 2009

FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice

scientific journal article

FoxO6 in glucose metabolism (FoxO6)

scientific article published on 28 May 2013

FoxO6 integrates insulin signaling with MTP for regulating VLDL production in the liver.

scientific article published on 17 January 2014

FoxO6 integrates insulin signaling with gluconeogenesis in the liver.

scientific article

FoxO6-mediated IL-1β induces hepatic insulin resistance and age-related inflammation via the TF/PAR2 pathway in aging and diabetic mice

scientific article published on 03 April 2019

Foxo1 mediates insulin action on apoC-III and triglyceride metabolism.

scientific article published on November 2004

Foxo1 mediates insulin-like growth factor 1 (IGF1)/insulin regulation of osteocalcin expression by antagonizing Runx2 in osteoblasts

scientific journal article

Glucose-regulated insulin production in the liver improves glycemic control in type 1 diabetic mice

scientific article published on November 2014

Hepatic insulin production for type 1 diabetes

scientific article

Impaired insulin secretion and enhanced insulin sensitivity in cholecystokinin-deficient mice.

scientific article

Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse.

scientific article published in July 2002

Increased hepatic levels of the insulin receptor inhibitor, PC-1/NPP1, induce insulin resistance and glucose intolerance.

scientific article

Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice

scientific journal article

Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction

scientific article (publication date: 29 May 2003)

Liver-specific inducible nitric-oxide synthase expression is sufficient to cause hepatic insulin resistance and mild hyperglycemia in mice

scholarly article by Shohei Shinozaki et al published 1 November 2011 in Journal of Biological Chemistry

Liver-specific inducible nitric-oxide synthase expression is sufficient to cause hepatic insulin resistance and mild hyperglycemia in mice.

scientific article

Overexpression of apolipoprotein C-III decreases secretion of dietary triglyceride into lymph

scientific article published on 20 March 2014

PPAR{alpha} mediates the hypolipidemic action of fibrates by antagonizing FoxO1

scientific article published on 19 September 2006

Proteomic analysis of fructose-induced fatty liver in hamsters

scientific article

Reactive oxygen species suppress cardiac NaV1.5 expression through Foxo1.

scientific article

SMAD3/Stat3 Signaling Mediates β-Cell Epithelial-Mesenchymal Transition in Chronic Pancreatitis-Related Diabetes.

scientific article published on 03 August 2017

Sex- and Tissue-Specific Role of Estrogen Sulfotransferase in Energy Homeostasis and Insulin Sensitivity

scientific article

Sirolimus is associated with reduced islet engraftment and impaired beta-cell function

scientific article published on 01 September 2006

Treatment with a Catalytic Superoxide Dismutase (SOD) Mimetic Improves Liver Steatosis, Insulin Sensitivity, and Inflammation in Obesity-Induced Type 2 Diabetes.

scientific article